Results 231 to 240 of about 339,726 (399)

A heroin overdose laboratory model: How do escalating doses of diamorphine alter respiratory function in a diamorphine‐treated population?

open access: yesAddiction, EarlyView.
Abstract Background & Aim Globally, more than 100 000 people die annually from opioid overdose. Although strongly implicated in heroin overdose deaths, acute opioid‐induced respiratory depression is poorly understood, and few laboratory studies have been completed in human subjects. It is an area of undone science.
Basak Tas   +10 more
wiley   +1 more source

Early identification of the use of potent benzylbenzimidazoles (nitazenes) through wastewater analysis: Two years of data from 22 countries

open access: yesAddiction, EarlyView.
Abstract Background and Aims The use of new synthetic opioids, such as the highly potent 2‐benzylbenzimidazoles (i.e. nitazene) drugs, is a global health concern because of their increased risk of fatal overdose. In the early 2020s, nitazene analogues were linked to significant numbers of overdoses in the United States.
Richard Bade   +5 more
wiley   +1 more source

Morphin

open access: yesDelaware Journal of Public Health, 2017
openaire   +3 more sources

The Morphine Manifesto [PDF]

open access: yesTidsskrift for Den norske legeforening, 2012
Ola Dale   +2 more
openaire   +3 more sources

Naloxone dosing in the era of synthetic opioids: Applying the Goldilocks principle

open access: yesAddiction, EarlyView.
Abstract The opioid overdose epidemic remains a critical public health crisis. In recent years, synthetic opioids like fentanyl and nitazenes, have driven a sharp rise in deaths. Naloxone, an opioid receptor antagonist, has been established as a key intervention for reversing opioid overdoses and saving lives.
Mariana Gonzalez Utrilla   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy